solution, either 1 or 2 per cent., was made in freshly distilled sterile water or sterile saline. A freshly prepared solution was used. Injections were given intravenously every third day, unless there was indication that a longer interval between doses was advisable. In most cases, the initial dose was I c.cm., which was very gradually increased. More than 4 c.cm. of a 1 per cent. solution was rarely given. Reactions were not unusual following the use of this drug. The most frequent reaction observed was severe coughing, with expectoration of blood-stained sputum, accompanied by cyanosis, dyspncea and fever. Such a reaction followed immediately upon the intravenous injection of the drug and all the symptoms except fever passed off within a very short time. Nausea and vomiting were not unusual, either accompanying such attacks as are described above, or alone. If any of the solution escaped into the surrounding tissues during administration, there was immediate acute pain, soon followed by redness and swelling of the area infiltrated, and often resulting in necrosis of the involved tissues.
ANTIMOSAN (Heyden 661) . This is a complex salt of antimony oxide and a non-toxic derivative of pyrocatechin. It contains trivalent antimony, about 125 per cent. 4 This drug was prepared in sterile distilled water, 5 per cent. solution, and given intravenously, beginning with I and gradually increasing to 2 c.cm. It was possible to give the drug on successive days, but in most cases it was given on alternate days. STIBAMINE GLUCOSIDE. This is an aromatic compound allied to sodium para-amino-phenyl-stibiate, with V.2
For the sake of convenience, the antimony preparations used are designated by letters, as indicated in Table 1 . Facts concerning the patients treated by these antimony preparations are arranged in corresponding groups designated A, B, C, D, E, F respectively. Owing to the small number of cases in groups B and F, these groups are not included in the detailed study of the cases. Of the 134 patients in Table 1 , 3 were discharged against advice before treatment was finished, and 22 died during the course of treatment. 
SERIES.
Anitimiionly preparation.
(a)
.f)
Cause not established Table 3 shows the list of diseases complicating kala azar in our series of children. The period during treatment is practically covered by the services of two physicians. The change of physicians was made in 1924. We feel, from our more recent investigations, that the incidence of spirochaetal The dose was gradually increased to 3 c.cm. near the end of the treatment. Three injections were given each week, excepting the fifth and, sixth weeks, when the drug was withheld because of enlarged tender cervical glands. At the end of five months, the patient had received 76 c.cm. of the drug. Reactions following injections were, enlarged tender cervical glands noted above, and an attack of coughing following an injection, when the total amount of 27-5 c.cm. had been given. By the end of the course of treatment the enlargement of the spleen had diminished from 17 cm. to 95 cm., the hiemoglobin had increased from 50 to 90 per cent., and the red blood cells from 2,895,000 to 5,760,000. There was a gain in weight of 2-5 kgrm. A letter Illustrative Case (Group D).-Male, about .5 years of age. Patient was brought to hospital by a friend of the family who said the patient had been suffering from afternoon fever for one month, and that the parents of the patient had noticed for one month a mass below the left costal margin. Patient remained in hospital 10 weeks receiving stibosan up to a total of 1-49 grm. The drug was given on alternate days intravenously in 2 per cent. solution. An initial dose of 0 03 grm. was gradually increased to 0-08 grm. near the end of the course. Ten weeks after this treatment was finished, the patient returned to hospital for re-examination. While at home, patient had lost kilo 2-270. The spleen was 1 cm. smaller than at time of discharge. L. donovani bodies were found in spleen puncture films. Stibosan was again given as in first course. Because of illness in family, patient was taken home when a total of 0-63 grm. had been given. One month after second discharge, patient returned for examination. Twenty-six months after last visit, a report indicated that patient was completely cured of kala azar. GROUP E. There remain for consideration the group of cases treated by neostibosan by intravenous and intramuscular injections. 
Average days in hospital, 30. Total average dose of drug, 1-6 grm.
Average number of injections, 11. ,
to fall of temperature, 9.
,, amount of drug to fall of temperature, 1-47 grm. Illustrative Cases (Group E).-(i) Female, 3 yr. 2 months of age. Ill with kala 'azar 7 months before admission; spleen enlarged 5 months. During first stay in hospital, patient received neostibosan intravenously, total dose of 1-6 grm. Doses of 0-1 grm. were given on successive days, except the third day when 0-2 grm. was given. There was no reaction following the injections. One month after treatment ,"as finished, patient returned for observation and it was found that the spleen had enlarged during the interval. At this time a second course, total amount of neostibosan 0 5 grm. was given intravenously. A letter written 20 months after the last injection indicated that the patient was completely cured of kala azar.
(2). Male, 8 years of age, ill with kala azar for 12 months. Spleen had been enlarged for about one year. Patient received intramuscular injections of neostibosan, a total of 1-7 grm. The drug was administered in doses of 0-1 grm. first day in hospital and 0-2 grm. on alternate days, until the full amount had been 
